-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
*For medical professionals only
It is best not to use hypoglycemic drugs! Diabetic gastroparesis (DGP) refers to the gastric emptying delay syndrome that occurs in patients with diabetes without mechanical obstruction, manifested by repeated nausea, vomiting, postprandial fullness, early saturation and bloating, with or without abdominal pain, and weight loss
References:
[1] Gong Wenwen, Han Yaliang, Tang Zhizhi, et al.Research progress in clinical treatment of diabetic gastroparesis[J].
Journal of PLA Medical College,2021,42(11):1216-1219, 1224.
[2] KalraS, Sharma A, Priya G.
Diabetic Gastroparesis[J].
Diabetes Ther, 2018, 9(5): 1723‑1728.
DOI: 10.
1007/s13300‑018‑0475‑4.
[3] Grover M, Farrugia G, Stanghellini V.
Gastroparesis: aturning point in understanding and treatment.
[J] Gut,2019,68(12): 2238-2250.
DOI: 10.
1136/gutjnl-2019-318712.
ZHANG Huafang.
Efficacy evaluation of gastric reassuscitation combined with domperidone in the treatment of diabetic gastroparesis in 20 cases[J ].
Aerospace Medicine,2010,21( 4 ):550-551.
Zou Ruizheng, Liu Chang, Wang Jun, et al.
Effect of erythromycin on intestinal flora and circulating inflammatory factors in the treatment of diabetic gastroparesis[J].
Chongqing Medical Sciences,2016,45( 4 ):478-480.
[6] Shakir AK, Altaf MA.
Azithromycin induces migrating motor complexes in pediatric patients undergoing antroduodenal motility studies[J].
J Pediatr Pharmacol Ther, 2018, 23(5): 390-394.
DOI: 10.
5863/1551-6776-23.
5.
390.
[7] Ma Lijun,Zhu Yufen,Ma Lei.
Clinical observation of Moshabili in the treatment of gastric paresis in the elderly with type 2 diabetes mellitus[J].
Chinese Health Standards Administration,2016,7( 15 ):118-119.
[8] Chen H, Hong F, Chen Y, et al.
Activation of islet 5‑HT4 receptor regulates glycemic control through promoting insulin secretion[J].
Eur J Pharmacol, 2016, 789: 354‑361.
DOI: 10.
1016/j.
ejphar.
2016.
07.
024.
Wu Jianguo.
Effect of helicobacter pylori infection eradication therapy and blood glucose level on gastroparesis in patients with type 2 diabetes[J].
Chinese Medical Sciences,2019,9(9):240-243.
Zhao Xuelian,Guo Wenjuan.
Observation on the effect of mosalpride combined with methylcobalamin in the treatment of gastroparesis in elderly diabetes[J ] .
Chinese Therapeutic Medicine,2016,25( 6 ):647-648.
Sun Junping,Han Yaoguang.
Efficacy of Citrus aurantium kuanzhong capsule combined with methylcobalamin tablets in the treatment of diabetic gastroparesis[J].
Chinese Journal of Integrative Traditional Chinese and Western Medicine Digestion,2018,26(12):1040-1042.
Dai Guixue.
Effect of methylcobalamin combined with mosalpride in the treatment of patients with diabetic gastroparesis[J].
China Minkang Medicine,2020,32( 6 ):38-39.
[13] Malamood M, Roberts A, Kataria R, et al.
Mirtazapine for symptom control in refractory gastroparesis[J].
Drug Des Devel Ther, 2017, 11: 1035‑1041.
DOI: 10.
2147/DDDT.
S125743.
[14] Li Jiuwen,Lu Na.
Gastric motility changes in type 2 diabetes mellitus and the efficacy of mosalpride citrate on patients with diabetic gastroparesis[J].
Chongqing Medical Journal,2014,43(7):840-842.
Qu Huiqin,Qu Congling.
Effects of mosalpride combined with domperidone on gastric motility and blood glucose control in patients with long-term type 2 diabetes mellitus and gastroparesis[J].
Hebei Medical And Pharmaceutical Journal,2017,39(24):3708-3711.
Shen Wei.
Discussion on the effect of gastric fuse combined with itobide in the treatment of diabetic gastroparesis[J].
New World of Diabetes,2020,23(1):66-67.
Tang Xudong, Wang Fengyun, Li Huizhen, et al.
Clinical Practice Guidelines of Traditional Chinese Medicine (2018)[J].
Journal of Traditional Chinese Medicine,2019,60(17):1520-1530.
Fan Li.
Efficacy of erythromycin and mosabide in the treatment of diabetic gastroparesis[J].
Medical Theory & Practice,2015,28(9):1193-1194.
] Luo Xuan,Wei Shaoheng.
Clinical observation of itobide hydrochloride combined with α-lipoic acid in the treatment of diabetic gastroparesis[J].
Contemporary Medicine,2017,23(19):59-60.
Zhang Zijian, Yan Chen, Zhang Minghui, et al.
Systematic review of moxabide in the treatment of diabetic gastroparesis[J].
Chinese Hospital Drug Evaluation and Analysis,2015,15(3):314-317.
Liu Li, Sun Li.
Efficacy analysis of α-lipoic acid combined with mosapride in the treatment of diabetic gastroparesis[J].
Electronic Journal of Clinical Medical Literature,2018,5(78):56-57.